The safety profile of AstraZeneca PLC’s COVID-19 vaccine has received backing from medicines regulators in the EU and the UK, even though both concluded it is likely to raise the risk of very rare but sometimes fatal blood clots.
The safety reviews looked at cases of thrombosis occurring together with low levels of platelets (thrombocytopenia), in particular brain blood...







